EUVIMEDAvasta EUVIMED
Crossref

Researchers urge slow tapers in deprescribing study for pediatrics

Alison Knopf

The Brown University Child & Adolescent Psychopharmacology Update · 2026-05 · 28 (5) · 1-4

DOI: 10.1002/cpu.31059 ↗

At a glance

Journal article in The Brown University Child & Adolescent Psychopharmacology Update, published online on 2026-04-27. Written by Alison Knopf.

AbstraktBibliograafilised andmedCiteRelated studies

Abstract (original language)

Deprescribing antidepressants for children and adolescents should be guided by data as well as observation of the patient's relapse and withdrawal symptoms, according to a new study. Clinicians should also consider the pharmacokinetic and pharmacodynamic properties of medications, including when and how to initiate deprescribing, the researchers add. These considerations are critically important to the clinician‐family‐patient relationship.

Cite

APA

Knopf, A. (2026). Researchers urge slow tapers in deprescribing study for pediatrics. The Brown University Child & Adolescent Psychopharmacology Update, 28(5), 1-4. https://doi.org/10.1002/cpu.31059

Vancouver

Knopf A. Researchers urge slow tapers in deprescribing study for pediatrics. The Brown University Child & Adolescent Psychopharmacology Update. 2026;28(5):1-4. doi:10.1002/cpu.31059

BibTeX
@article{Knopf2026,
  author = {Knopf, Alison},
  title = {Researchers urge slow tapers in deprescribing study for pediatrics},
  journal = {The Brown University Child & Adolescent Psychopharmacology Update},
  year = {2026},
  volume = {28},
  number = {5},
  pages = {1--4},
  doi = {10.1002/cpu.31059}
}
Start for free →